A phase 2 study of itacitinib for the prevention of cytokine release syndrome (CRS) induced by immune effector cell (IEC) therapy: Preliminary results Meeting Abstract
| Authors: | Frigault, M. J.; Maziarz, R. T.; Lazaryan, A.; Frey, N. V.; Assal, A.; Shah, N. N.; Lekakis, L. J.; Park, J. H.; Phillips, C. L.; Burke, L.; Lakshminarayanan, M.; Morariu-Zamfir, R.; DiPersio, J. F. |
| Abstract Title: | A phase 2 study of itacitinib for the prevention of cytokine release syndrome (CRS) induced by immune effector cell (IEC) therapy: Preliminary results |
| Meeting Title: | 48th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT) |
| Journal Title: | Bone Marrow Transplantation |
| Volume: | 57 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2022 Mar 19-23 |
| Meeting Location: | Virtual |
| ISSN: | 0268-3369 |
| Publisher: | Nature Publishing Group |
| Date Published: | 2022-11-02 |
| Start Page: | 72 |
| End Page: | 73 |
| Language: | English |
| ACCESSION: | WOS:000878153300109 |
| PROVIDER: | wos |
| PMCID: | PMC9628429 |
| PUBMED: | 36323939 |
| DOI: | 10.1038/s41409-022-01815-2 |
| Notes: | Meeting Abstract: O116 -- located in section, "Oral Sessions (O009-O155)" -- Source: Wos |
